Special purpose acquisition companies, or spacs. Bain capital launches life sciences spac.
B cls acquisition, a blank check company formed by bain capital life sciences targeting the healthcare industry, filed on friday with the sec to raise up to $125 million in.
Bain capital life sciences spac. Managing director, bain capital life sciences. Pharmaceutical company eqrx and cm life sciences iii today announced a definitive business combination agreement that would provide up to $1.8 billion in cash proceeds to eqrx. Let’s start with a good example:
Unlike other intelligence solutions, bciq exclusively supports the unique. For the biopharma industry investment, business development and competitive intelligence professionals who require information to support financing, partnering and licensing activities, bciq provides accurate information and context to support profitable and strategic decision making. And cm life sciences iii, inc.
Experts from the life sciences industry shared their insights on the steps to going public in a virtual summit hosted by woodruff sawyer.the summit featured leaders representing cooley, the new york stock exchange (nyse), deloitte, ambrx, cowen, jp morgan, maze therapeutics, bain capital life sciences, gilmartin, mammoth biosciences, newyorkbio,. Bain capital life sciences pursues investments in pharmaceutical, biotechnology, medical device, diagnostic, and life science tool companies across the globe. Aug 6, 2021, spac research.
Our sponsor is an affiliate of bain capital life sciences, a leading life sciences investment manager with over $2.2 billion of assets under management as of june 30, 2020. The transaction is expected to provide up to $1.8 billion in cash proceeds to eqrx,. People our team draws upon individuals with senior experience in both the life science industry as well as public and private healthcare investing.
Arya sciences, which is sponsored by the hedge fund perceptive advisors, has already raised $150 million, and expects proceeds of some $320 million from a wide range of healthcare investors as a result of the cerevel deal. Eqrx, inc., a new type of pharmaceutical company committed to developing and delivering important new medicines to patients at radically lower prices, and cm life sciences iii, inc. What kind of biotech should look for a spac acquisition?
Rowe price and ra capital, as well as existing cerevel shareholders pfizer and bain. Jeffrey schwartz is a managing director of bain capital life sciences, where he is a founding member of the team. Bcls acquisition, a blank check company formed by bain capital life sciences targeting the healthcare industry, raised $125 million by offering 12.5 million shares at $10.
The spac did not offer. Financing includes approximately $552 million of cash held in the spac's trust (assuming no redemptions), and a fully committed pipe of $1.2 billion from healthcare. Oct 2, 2020 6:23pm edt.